The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Idera's Hep C Drug Put on Hold

Back to News Homepage

Next

FDA Backs Telaprevir for Having High Hepatitis C Cure Rate

Hep C Drug Boceprevir is Faster and Better

May 4, 2011

Print this page

The FDA reported encouraging news regarding Merck’s Hepatitis C drug, boceprevir.

FDA says Merck hepatitis drug a faster cure

April 26, 2011 | By David Sell, Inquirer Staff Writer

Merck researchers in North Wales and Kenilworth, N.J., received some tentative but good news Monday when Food and Drug Administration staff members reported that Merck’s drug to fight the hepatitis C virus cured most patients faster and more completely than older medications during clinical trials.

Continue reading this entire article:
http://articles.philly.com/2011-04-26/business/29474900_1_hepatitis-c-virus-fda-approval-fda-advisory-committee

No Comments - be the first!
Share
Share

Previous

Idera's Hep C Drug Put on Hold

Back to News Homepage

Next

FDA Backs Telaprevir for Having High Hepatitis C Cure Rate

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.